AMRI dd-sheet.
fourth quarter and full year financial results before the opening of the market on Tuesday, February 12, 2013 10 AM ET . Following the release of its results, the company will host a conference call and simultaneous webcast.
For more than 20 years, as Albany Molecular Research Inc. (AMRI), we have provided fully integrated drug discovery, development and manufacturing services – all while adapting to the rapidly changing needs of our customers within the pharmaceutical, biotechnology and related industries.
Major Stock Holders. Inc Mutual Funds.
O/S 10-Q 11/8/12
30,924,480 excluding treasury shares of 5,411,372
12/6/12 AMRI Extends Long Term Supply Relationship with GE Healthcare
cGMP Manufacturing 
Aseptic Fill & Finish You Tube.
http://www.youtube.com/watch?v=W5u7ubc28g4&am...r_embedded
Developement 
(0)
(0)
